EP3093345B8
(en)
|
2007-07-26 |
2019-07-24 |
UniQure IP B.V. |
Baculoviral vectors comprising repeated coding sequences with differential codon biases
|
US20110030075A1
(en)
|
2008-01-29 |
2011-02-03 |
Proyecto De Biomedicina Cima S.L. |
Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner
|
AU2009215987B2
(en)
*
|
2008-02-19 |
2015-01-22 |
Uniqure Ip B.V. |
Optimisation of expression of parvoviral rep and cap proteins in insect cells
|
EP2352823B1
(en)
*
|
2008-09-29 |
2014-08-06 |
UniQure IP B.V. |
Porphobilinogen deaminase gene therapy
|
JP5728389B2
(ja)
|
2009-01-30 |
2015-06-03 |
ユニキュアー アイピー ビー.ブイ. |
アラニン−グリオキシル酸アミノトランスフェラーゼ治療薬
|
JP2012521750A
(ja)
|
2009-03-27 |
2012-09-20 |
プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ |
肝硬変及び肝線維症の治療のための方法及び組成物
|
EP2500434A1
(en)
*
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
TWI702955B
(zh)
|
2012-05-15 |
2020-09-01 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
DK3889173T3
(da)
|
2013-02-15 |
2023-10-09 |
Bioverativ Therapeutics Inc |
Optimeret faktor viii-gen
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
CN105705140A
(zh)
|
2013-11-05 |
2016-06-22 |
克隆技术实验室有限公司 |
干转染组合物及其制备和使用方法
|
EA201691809A1
(ru)
*
|
2014-03-10 |
2017-01-30 |
ЮНИКЬЮРЕ АйПи Б.В. |
Дополнительно усовершенствованные векторы aav, продуцируемые клетками насекомого
|
AU2015231439B2
(en)
|
2014-03-17 |
2019-11-14 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression in cone cells
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
MX2017005834A
(es)
|
2014-11-05 |
2017-11-17 |
Voyager Therapeutics Inc |
Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
KR102599909B1
(ko)
|
2014-11-14 |
2023-11-09 |
보이저 테라퓨틱스, 인크. |
근위축성 측삭 경화증(als)을 치료하는 조성물 및 방법
|
RU2749882C2
(ru)
|
2014-11-14 |
2021-06-18 |
Вояджер Терапьютикс, Инк. |
Модулирующие полинуклеотиды
|
CN107208142B
(zh)
|
2014-11-28 |
2024-03-26 |
优尼科Ip有限公司 |
包含细小病毒病毒体的组合物中的dna杂质
|
EP3230441A4
(en)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
LT3237618T
(lt)
|
2014-12-24 |
2019-07-10 |
Uniqure Ip B.V. |
Rnri sukeltas hantingtino geno slopinimas
|
KR20170137730A
(ko)
|
2015-03-02 |
2017-12-13 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
PT3411478T
(pt)
|
2016-02-01 |
2022-09-13 |
Bioverativ Therapeutics Inc |
Genes do fator viii otimizados
|
EP4159867A1
(en)
|
2016-03-28 |
2023-04-05 |
Ultragenyx Pharmaceutical Inc. |
Methods of heat inactivation of adenovirus
|
KR20230156167A
(ko)
*
|
2016-04-16 |
2023-11-13 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
바큘로바이러스 시스템-생산된 재조합 아데노-연관 바이러스의 생물학적 효력을 증진시키는 방법
|
WO2017189959A1
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
CN116333057A
(zh)
|
2016-05-13 |
2023-06-27 |
4D分子治疗有限公司 |
腺相关病毒变体衣壳和其使用方法
|
IL302748A
(en)
|
2016-05-18 |
2023-07-01 |
Voyager Therapeutics Inc |
modulatory polynucleotides
|
SG11201809643UA
(en)
|
2016-05-18 |
2018-12-28 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
KR20190020745A
(ko)
*
|
2016-06-15 |
2019-03-04 |
옥스포드 유니버시티 이노베이션 리미티드 |
Abc4a를 발현시키기 위한 이중 중첩 아데노-관련 바이러스 벡터 시스템
|
US11698377B2
(en)
*
|
2016-08-15 |
2023-07-11 |
Genzyme Corporation |
Methods for detecting AAV
|
CN110225975A
(zh)
|
2016-08-23 |
2019-09-10 |
阿库斯股份有限公司 |
用于治疗人受试者中非年龄相关的听力损害的组合物和方法
|
AU2017321488B2
(en)
|
2016-08-30 |
2022-10-20 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
EP3526321A4
(en)
|
2016-10-14 |
2020-05-13 |
Ultragenyx Pharmaceutical Inc. |
USE OF TONIFYING AGENTS TO IMPROVE THE YIELD OF RECOMBINANT ADENO-ASSOCIATED VIRUS
|
CA3045551A1
(en)
|
2016-12-16 |
2018-06-21 |
Uniqure Ip B.V. |
Immunoadsorption
|
US11028131B2
(en)
*
|
2017-01-30 |
2021-06-08 |
Nippon Medical School Foundation |
Mutant of adeno-associated virus (AAV) capsid protein
|
WO2018175775A1
(en)
|
2017-03-22 |
2018-09-27 |
Dimension Therapeutics |
Cell culture methods involving hdac inhibitors or rep proteins
|
WO2018204786A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
EA202090260A1
(ru)
|
2017-07-10 |
2020-05-08 |
ЮНИКЬЮРЕ АйПи Б.В. |
Средства и способы для генотерапии aav у человека
|
CN111132626B
(zh)
|
2017-07-17 |
2024-01-30 |
沃雅戈治疗公司 |
轨迹阵列引导系统
|
WO2019016349A1
(en)
|
2017-07-20 |
2019-01-24 |
Uniqure Ip B.V. |
PRODUCTION OF ENHANCED VAA CAPSIDS IN INSECT CELLS
|
EP3662060A2
(en)
|
2017-08-03 |
2020-06-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
KR20220070075A
(ko)
|
2017-09-20 |
2022-05-27 |
4디 몰레큘러 테라퓨틱스 아이엔씨. |
아데노-관련 바이러스 변이체 캡시드 및 그 용도
|
US20200231986A1
(en)
|
2017-09-29 |
2020-07-23 |
Massachusetts Eye And Ear Infirmary |
Production of adeno-associated viruses in insect cells
|
EP3697908A1
(en)
|
2017-10-16 |
2020-08-26 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
TWI804518B
(zh)
|
2017-10-16 |
2023-06-11 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
CN111770999A
(zh)
|
2017-11-27 |
2020-10-13 |
4D分子治疗有限公司 |
腺相关病毒变体衣壳和用于抑制血管生成的应用
|
CA3084452A1
(en)
|
2017-12-29 |
2019-07-04 |
Uniqure Ip B.V. |
Modified viral vectors and methods of making and using the same
|
DK3740222T3
(da)
|
2018-01-17 |
2023-07-31 |
Meiragtx Uk Ltd |
Modificeret RAAV-capsidprotein til genterapi
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
WO2019161365A1
(en)
|
2018-02-19 |
2019-08-22 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof
|
WO2019195701A1
(en)
|
2018-04-05 |
2019-10-10 |
Massachusetts Eye And Ear Infirmary |
Methods of making and using combinatorial barcoded nucleic acid libraries having defined variation
|
US20210230632A1
(en)
|
2018-05-15 |
2021-07-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
MA52631A
(fr)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics Inc |
Compositions et méthodes pour le traitement de la maladie de parkinson
|
EP3793686A1
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
EP3807404A1
(en)
|
2018-06-13 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Engineered 5' untranslated regions (5' utr) for aav production
|
CA3107462A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
US20210277418A1
(en)
|
2018-08-03 |
2021-09-09 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
CA3112007A1
(en)
|
2018-09-12 |
2020-03-19 |
Uniqure Ip B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
AU2019346655A1
(en)
|
2018-09-28 |
2021-05-06 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
TW202028458A
(zh)
|
2018-10-05 |
2020-08-01 |
美商航海家醫療公司 |
編碼腺相關病毒(aav)生產蛋白之經基因工程化核酸構築體
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
US20210395777A1
(en)
|
2018-10-15 |
2021-12-23 |
Voyager Therapeutics, Inc. |
EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM
|
US11702673B2
(en)
|
2018-10-18 |
2023-07-18 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
WO2020104469A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Method and means to deliver mirna to target cells
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
CN113383077A
(zh)
|
2018-11-19 |
2021-09-10 |
优尼科Ip有限公司 |
RNAi诱导的ataxin-3减少以用于治疗脊髓小脑共济失调3型
|
WO2020104435A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
AU2020208467A1
(en)
|
2019-01-18 |
2021-08-05 |
Voyager Therapeutics, Inc. |
Methods and systems for producing AAV particles
|
TW202045529A
(zh)
|
2019-02-15 |
2020-12-16 |
美商聖加莫治療股份有限公司 |
用於生產重組aav之組合物及方法
|
JP2022521025A
(ja)
|
2019-02-25 |
2022-04-04 |
ノバルティス アーゲー |
Biettiクリスタリン網膜症を治療するための組成物及び方法
|
JP2022520875A
(ja)
|
2019-02-25 |
2022-04-01 |
ノバルティス アーゲー |
Biettiクリスタリン網膜症を治療するための組成物及び方法
|
MX2021010412A
(es)
|
2019-02-28 |
2022-01-24 |
Benitec Ip Holdings Inc |
Composiciones y metodos para tratar distrofia muscular oculofaringea (opmd).
|
US20220186193A1
(en)
*
|
2019-04-12 |
2022-06-16 |
Massachusetts Eye & Ear Infirmary |
METHODS AND COMPOSITIONS FOR IMPROVING THE ASSEMBLY OF ADENO-ASSOCIATED VIRUSES (AAVs)
|
SG11202110904PA
(en)
|
2019-04-12 |
2021-10-28 |
Ultragenyx Pharmaceutical Inc |
Engineered producer cell lines and methods of making and using the same
|
TW202106879A
(zh)
|
2019-04-29 |
2021-02-16 |
美商航海家醫療公司 |
於生物反應器中生產經桿狀病毒感染之昆蟲細胞(biic)之系統及方法
|
MX2022000551A
(es)
|
2019-07-15 |
2022-05-18 |
Meiragtx Uk Ii Ltd |
Proteínas de la cápside de aav modificadas para el tratamiento de una enfermedad artrítica.
|
US10653731B1
(en)
|
2019-07-15 |
2020-05-19 |
Vigene Biosciences Inc. |
Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
|
US10801042B1
(en)
|
2019-07-15 |
2020-10-13 |
Vigene Biosciences, Inc. |
Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus
|
US10557149B1
(en)
|
2019-07-15 |
2020-02-11 |
Vigene Biosciences, Inc. |
Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
|
US20220281922A1
(en)
|
2019-08-02 |
2022-09-08 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
US20220364114A1
(en)
|
2019-08-26 |
2022-11-17 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
KR20220076510A
(ko)
|
2019-10-08 |
2022-06-08 |
트러스티스 오브 보스톤 칼리지 |
다수의 서로 다른 비천연 아미노산을 함유하는 단백질 및 이러한 단백질의 제조 및 사용 방법
|
IL293397A
(en)
|
2019-12-04 |
2022-07-01 |
Sangamo Therapeutics Inc |
New preparations and methods for the production of recombinant aav
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
JP2023515072A
(ja)
|
2020-02-21 |
2023-04-12 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
|
AU2021357520A1
(en)
|
2020-03-05 |
2022-09-29 |
Neotx Therapeutics Ltd. |
Methods and compositions for treating cancer with immune cells
|
BR112022018658A2
(pt)
|
2020-03-16 |
2022-12-20 |
Ultragenyx Pharmaceutical Inc |
Métodos para potencializar o rendimento de vírus adenoassociado recombinante
|
WO2021198510A1
(en)
|
2020-04-02 |
2021-10-07 |
Uniqure Biopharma B.V. |
Novel cell line
|
AU2021250656A1
(en)
|
2020-04-02 |
2022-09-15 |
Uniqure Biopharma B.V. |
Dual bifunctional vectors for AAV production
|
WO2021204872A1
(en)
|
2020-04-07 |
2021-10-14 |
Uniqure Ip B.V. |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
IL297200A
(en)
|
2020-04-15 |
2022-12-01 |
Voyager Therapeutics Inc |
tau binding compounds
|
BR112022023106A2
(pt)
|
2020-05-13 |
2023-01-17 |
Voyager Therapeutics Inc |
Redirecionamento de tropismo de capsídeos de aav
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
WO2022026410A2
(en)
|
2020-07-27 |
2022-02-03 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
CN112725344B
(zh)
*
|
2020-12-28 |
2023-05-12 |
中吉智药(南京)生物技术有限公司 |
密码子优化的smn1基因、腺相关病毒表达质粒及基因药物
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
EP4305157A1
(en)
|
2021-03-09 |
2024-01-17 |
Huidagene Therapeutics (Singapore) Pte. Ltd. |
Engineered crispr/cas13 system and uses thereof
|
EP4314258A1
(en)
|
2021-04-02 |
2024-02-07 |
uniQure biopharma B.V. |
Methods for producing single insect cell clones
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
US20240240206A1
(en)
|
2021-06-02 |
2024-07-18 |
Uniqure Biopharma B.V. |
Insect cell production of parvoviral vectors with modified capsid proteins
|
CA3219847A1
(en)
|
2021-06-02 |
2022-12-08 |
Sander Jan Hendrik Van Deventer |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
EP4359010A1
(en)
|
2021-06-21 |
2024-05-01 |
uniQure biopharma B.V. |
Improved lysis procedures
|
WO2022268835A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Gene constructs for silencing alpha-synuclein and uses thereof
|
WO2022269466A1
(en)
*
|
2021-06-22 |
2022-12-29 |
Pfizer Inc. |
Production of adeno-associated virus vector in insect cells
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
WO2023025920A1
(en)
|
2021-08-26 |
2023-03-02 |
Uniqure Biopharma B.V. |
Insect cell-produced high potency aav vectors with cns-tropism
|
EP4405396A2
(en)
|
2021-09-20 |
2024-07-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
WO2023077078A1
(en)
|
2021-10-29 |
2023-05-04 |
Ultragenyx Pharmaceutical Inc. |
Engineered cell lines for increased production of recombinant adeno-associated virus (raav)
|
WO2023081648A1
(en)
|
2021-11-02 |
2023-05-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
CN114107390B
(zh)
*
|
2021-11-05 |
2023-10-24 |
中国科学院精密测量科学与技术创新研究院 |
一种用于表达抗体IgG1的rAAV载体及其应用
|
WO2023091949A2
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
WO2023091948A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2023147374A2
(en)
|
2022-01-25 |
2023-08-03 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
TW202346599A
(zh)
|
2022-02-08 |
2023-12-01 |
美商航海家醫療公司 |
Aav衣殼變異體及其用途
|
WO2023198745A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of apoe
|
WO2023198662A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Novel systems for nucleic acid regulation
|
WO2023198702A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of c9orf72
|
WO2023198663A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of snca
|
WO2023235791A1
(en)
|
2022-06-02 |
2023-12-07 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
WO2024006741A1
(en)
|
2022-06-28 |
2024-01-04 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2024011112A1
(en)
|
2022-07-06 |
2024-01-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2024030976A2
(en)
|
2022-08-03 |
2024-02-08 |
Voyager Therapeutics, Inc. |
Compositions and methods for crossing the blood brain barrier
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2024059739A1
(en)
|
2022-09-15 |
2024-03-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
CN116622742A
(zh)
*
|
2022-09-27 |
2023-08-22 |
睿征医药科技(武汉)有限公司 |
一种用于在昆虫细胞中产生rAAV的核酸、VP1衣壳蛋白突变体及应用
|
EP4349990A1
(en)
*
|
2022-10-07 |
2024-04-10 |
Certest Biotec, S.L. |
Artificial polynucleotides for expressing proteins
|
WO2024078584A1
(zh)
*
|
2022-10-13 |
2024-04-18 |
康霖生物科技(杭州)有限公司 |
腺相关病毒的衣壳蛋白编码基因改造方法
|